FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127462608> ?p ?o ?g. }

• W2127462608 endingPage "44" @default.
• W2127462608 startingPage "35" @default.
• W2127462608 abstract "To optimize patient management in breast cancer a number of factors are considered, including hormone receptor and HER2 status. A feasible approach for women with less aggressive, estrogen receptor/HER2-positive metastatic breast cancer is to consider trastuzumab (Herceptin; F. Hoffmann-La Roche, Basel, Switzerland) combined with endocrine therapy. Randomized clinical trials are ongoing to assess the combination of trastuzumab with aromatase inhibitors. In patients with aggressive HER2-positive metastatic breast cancer, trastuzumab/chemotherapy combination regimens are warranted. When administered first line in combination with a taxane, trastuzumab improves all clinical outcome parameters, including survival, in such patients. Trastuzumab adds little to the toxicity profile of taxanes, and trastuzumab combination therapy is associated with improvements in quality of life when compared with chemotherapy alone. There is encouraging evidence of improved efficacy when trastuzumab is combined with other cytotoxic agents with proven single-agent activity in breast cancer, including capecitabine (Xeloda; F. Hoffmann-La Roche), gemcitabine, and vinorelbine. Trastuzumab is also being investigated as part of triplet drug regimens. Trastuzumab has good single-agent activity in first-line therapy. This is of relevance to women with HER2-positive disease who are not suitable for, or do not wish to receive, cytotoxic chemotherapy. The benefits noted with trastuzumab-containing regimens were documented in clinical trials where trastuzumab was given until disease progression. A further rationale exists to continue trastuzumab beyond progression. Data from retrospective reviews indicate that this strategy is feasible." @default.
• W2127462608 created "2016-06-24" @default.
• W2127462608 creator A5003405177 @default.
• W2127462608 creator A5007286394 @default.
• W2127462608 creator A5035383163 @default.
• W2127462608 creator A5074121466 @default.
• W2127462608 creator A5079098518 @default.
• W2127462608 date "2004-10-01" @default.
• W2127462608 modified "2023-10-18" @default.
• W2127462608 title "Maximizing clinical benefit with trastuzumab" @default.
• W2127462608 cites W1603578607 @default.
• W2127462608 cites W1755920412 @default.
• W2127462608 cites W1783154753 @default.
• W2127462608 cites W1812067939 @default.
• W2127462608 cites W1836239578 @default.
• W2127462608 cites W1939003096 @default.
• W2127462608 cites W1940754997 @default.
• W2127462608 cites W1955744924 @default.
• W2127462608 cites W1966574632 @default.
• W2127462608 cites W1970341069 @default.
• W2127462608 cites W1971473564 @default.
• W2127462608 cites W1974681241 @default.
• W2127462608 cites W1987140112 @default.
• W2127462608 cites W1997838307 @default.
• W2127462608 cites W1998639325 @default.
• W2127462608 cites W2007256480 @default.
• W2127462608 cites W2009758504 @default.
• W2127462608 cites W2013246214 @default.
• W2127462608 cites W2019895529 @default.
• W2127462608 cites W2020499692 @default.
• W2127462608 cites W2023980148 @default.
• W2127462608 cites W2025689023 @default.
• W2127462608 cites W2035484878 @default.
• W2127462608 cites W2039310969 @default.
• W2127462608 cites W2048686497 @default.
• W2127462608 cites W2052953339 @default.
• W2127462608 cites W2069175206 @default.
• W2127462608 cites W2085772474 @default.
• W2127462608 cites W2089715930 @default.
• W2127462608 cites W2094627540 @default.
• W2127462608 cites W2095156669 @default.
• W2127462608 cites W2095540788 @default.
• W2127462608 cites W2096499163 @default.
• W2127462608 cites W2099658604 @default.
• W2127462608 cites W2109388713 @default.
• W2127462608 cites W2111897685 @default.
• W2127462608 cites W2112324274 @default.
• W2127462608 cites W2114167623 @default.
• W2127462608 cites W2114974083 @default.
• W2127462608 cites W2115759102 @default.
• W2127462608 cites W2123732467 @default.
• W2127462608 cites W2131770017 @default.
• W2127462608 cites W2132703026 @default.
• W2127462608 cites W2141393790 @default.
• W2127462608 cites W2143399650 @default.
• W2127462608 cites W2145257123 @default.
• W2127462608 cites W2146406055 @default.
• W2127462608 cites W2146681242 @default.
• W2127462608 cites W2149997750 @default.
• W2127462608 cites W2153242757 @default.
• W2127462608 cites W2155162231 @default.
• W2127462608 cites W2158158704 @default.
• W2127462608 cites W2159305151 @default.
• W2127462608 cites W2159459001 @default.
• W2127462608 cites W2162261674 @default.
• W2127462608 cites W2295658630 @default.
• W2127462608 cites W2318605753 @default.
• W2127462608 cites W4234783003 @default.
• W2127462608 doi "https://doi.org/10.1053/j.seminoncol.2004.07.020" @default.
• W2127462608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15490373" @default.
• W2127462608 hasPublicationYear "2004" @default.
• W2127462608 type Work @default.
• W2127462608 sameAs 2127462608 @default.
• W2127462608 citedByCount "36" @default.
• W2127462608 countsByYear W21274626082015 @default.
• W2127462608 crossrefType "journal-article" @default.
• W2127462608 hasAuthorship W2127462608A5003405177 @default.
• W2127462608 hasAuthorship W2127462608A5007286394 @default.
• W2127462608 hasAuthorship W2127462608A5035383163 @default.
• W2127462608 hasAuthorship W2127462608A5074121466 @default.
• W2127462608 hasAuthorship W2127462608A5079098518 @default.
• W2127462608 hasConcept C121608353 @default.
• W2127462608 hasConcept C126322002 @default.
• W2127462608 hasConcept C143998085 @default.
• W2127462608 hasConcept C2775930923 @default.
• W2127462608 hasConcept C2776694085 @default.
• W2127462608 hasConcept C2777511904 @default.
• W2127462608 hasConcept C2777909004 @default.
• W2127462608 hasConcept C2778239845 @default.
• W2127462608 hasConcept C2779786085 @default.
• W2127462608 hasConcept C2780258809 @default.
• W2127462608 hasConcept C2780350996 @default.
• W2127462608 hasConcept C526805850 @default.
• W2127462608 hasConcept C530470458 @default.
• W2127462608 hasConcept C535046627 @default.
• W2127462608 hasConcept C71924100 @default.
• W2127462608 hasConceptScore W2127462608C121608353 @default.
• W2127462608 hasConceptScore W2127462608C126322002 @default.

• next